Bayer wins crucial US Supreme Court ruling over Roundup weedkiller
Summary
The US Supreme Court overturned a verdict that had underpinned billions of dollars in Roundup-related claims tied to cancer-risk warnings. The decision strengthens Bayer’s position in ongoing and future litigation.
Why it matters
Lower litigation risk can unlock capital for Bayer and reset expectations for corporate exposure in mass-tort product cases.